Frontiers in Medicine (Oct 2022)
Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients
- Hatice Kilic,
- Emine Arguder,
- Aysegul Karalezli,
- Ebru Unsal,
- Rahmet Guner,
- Bircan Kayaslan,
- İmran Hasanoglu,
- İhsan Ates,
- Musa Civak,
- Esmehan Akpınar,
- Ebru Parlak,
- Filiz Sadi,
- Yasin Kocaman,
- Sibel Günay,
- Esra Metan,
- Mukremin Er,
- Aynil Dalkıran,
- Habibe Hezer,
- Hülya Ergüden,
- Zeynep Hancıoğlu,
- Ayşe Kalem,
- Fatma Eser,
- Adalet Aypak,
- Esragül Akıncı,
- Selma Karahmetoğlu,
- Emin Gemcioglu,
- Emra Kalkan,
- Osman İnan,
- Abdulrezzak Yilmaz,
- Bagdagul Güler,
- Esra Çopuroğlu,
- İşil Turan,
- Derya Gökmen,
- Serhat Hayme,
- Aziz Ahmet Surel
Affiliations
- Hatice Kilic
- Department of Pulmonary Medicine, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
- Emine Arguder
- Department of Pulmonary Medicine, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
- Aysegul Karalezli
- Department of Pulmonary Medicine, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
- Ebru Unsal
- Department of Pulmonary Medicine, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
- Rahmet Guner
- Department of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
- Bircan Kayaslan
- Department of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
- İmran Hasanoglu
- Department of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
- İhsan Ates
- Department of Internal Medicine Disease, Faculty of Medicine, Ankara University of Health Science, Ankara City Hospital, Ankara, Turkey
- Musa Civak
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
- Esmehan Akpınar
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
- Ebru Parlak
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
- Filiz Sadi
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
- Yasin Kocaman
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
- Sibel Günay
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
- Esra Metan
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
- Mukremin Er
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
- Aynil Dalkıran
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
- Habibe Hezer
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
- Hülya Ergüden
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
- Zeynep Hancıoğlu
- Department of Chest Diseases, Ankara City Hospital, Ankara, Turkey
- Ayşe Kalem
- Department of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
- Fatma Eser
- Department of Infectious Disease, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey
- Adalet Aypak
- Department of Infectious Disease, Faculty of Medicine, University of Health Science, Ankara, Turkey
- Esragül Akıncı
- Department of Infectious Disease, Faculty of Medicine, University of Health Science, Ankara, Turkey
- Selma Karahmetoğlu
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
- Emin Gemcioglu
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
- Emra Kalkan
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
- Osman İnan
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
- Abdulrezzak Yilmaz
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
- Bagdagul Güler
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
- Esra Çopuroğlu
- Department of Internal Medicine Diseases, Ankara City Hospital, Ankara, Turkey
- İşil Turan
- Department of Anesthesia, Ankara City Hospital, Ankara, Turkey
- Derya Gökmen
- Department of Biostatistics, School of Medicine, Ankara University, Ankara, Turkey
- Serhat Hayme
- Department of Biostatistics, School of Medicine, Ankara University, Ankara, Turkey
- Aziz Ahmet Surel
- Department of General Surgery, Ankara City Hospital, Ankara, Turkey
- DOI
- https://doi.org/10.3389/fmed.2022.957598
- Journal volume & issue
-
Vol. 9
Abstract
BackgroundThe aim of the study is to assess the effect of chronic lung disease on mortality in patients hospitalized with the diagnosis of prevariant COVID-19 Pneumonia compared to patients without chronic lung disease.Research design and methodsA cohort of 1,549 patients admitted to the pandemic clinic with a COVID-19 Pneumonia diagnosis was analyzed. Group 1 and Group 2 were compared in terms of the treatment they received, admission to intensive care, mortality and follow-up parameters.ResultsThe patient group with COVID-19 and lung disease consisted of 231 participants (14.91%) (Group 1). The patient group with COVID-19 but without lung disease had 1,318 participants (85.19%). Group 1 cases were found to receive more oxygen therapy and mechanical ventilation than Group 2 cases (p ≤ 0.001), Following univariate and multiple logistic regression analyses, it was determined that patients with chronic lung disease had a 25.76% higher mortality risk [OR: 25.763, 95% CI (Lower-Upper) (2.445–271.465), p = 0.007].ConclusionIt was found that chronic lung disease contributed significantly to mortality in this study. Among chronic lung diseases, Chronic Obstructive Pulmonary Disease (COPD), lung cancer and interstitial lung diseases (ILDs) were shown to be more effective than other chronic lung diseases in patients with prevariant COVİD-19 population.
Keywords
